Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

Murphy, Adrianna; Palafox, Benjamin; O’Donnell, Owen; Stückler, David; Perel, Pablo; F. AlHabib, Khalid; Avezum, Álvaro; Bai, Xiulin; Chifamba, Jephat; Kayei Chow, Clara; J. Corsi, Daniel; R. Dagenais, Gilles; L Dans, Antonio; Díaz, Rafael; Naciye Erbakan, Ayşe; Hassim Ismail, Noor; Iqbal, Romaina; Kelishadi, Roya; Khatib, Rasha; Tomas Lanas, Fernando; Alexander Lear, Scott; Li, Wei; Liu, Jia; López‐Jaramillo, Patricio; Mohan, Viswanathan; AbdulKhaleq Monsef, Nahed; Kumar Mony, Prem; Rose Puoane, Thandi; Rangarajan, Sumathy; Rosengren, Annika; Elisabeth Schutte, Aletta; Sintaha, Mariz; Kang Teo, Koon; T. Wielgosz, Andreas; Yeates, Karen; Yin, Lu; Yusoff, Khalid; Zatońska, Katarzyna; Yusuf, Salim; McKee, Martin

doi:10.1016/s2214-109x(18)30031-7

Public

Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

Shared by NobleBlocks on Feb 9, 2018 • 12:00 AM UTC

Authors:

Adrianna Murphy

Benjamin Palafox

Owen O’Donnell

Abstract

BACKGROUND: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. METHODS: We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals ...

Subject

Medicine

Tanzania

Socioeconomic status

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!